The Ongoing Battle Against Influenza: Drug-resistant influenza viruses: why fitness matters

The Ongoing Battle Against Influenza: Drug-resistant influenza viruses: why fitness matters

[1]  David Baltimore,et al.  Permissive Secondary Mutations Enable the Evolution of Influenza Oseltamivir Resistance , 2010, Science.

[2]  Alicia M. Fry,et al.  Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus Infections, United States, 2010–11 , 2012, Emerging infectious diseases.

[3]  D. Baltimore,et al.  A Computational-Experimental Approach Identifies Mutations That Enhance Surface Expression of an Oseltamivir-Resistant Influenza Neuraminidase , 2011, PloS one.

[4]  A. Monto,et al.  Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets. , 2004, The Journal of infectious diseases.

[5]  S. van der Werf,et al.  Enzymatic Properties of the Neuraminidase of Seasonal H1N1 Influenza Viruses Provide Insights for the Emergence of Natural Resistance to Oseltamivir , 2008, PLoS pathogens.

[6]  David W. Smith,et al.  Characteristics of a Widespread Community Cluster of H275Y Oseltamivir-Resistant A(H1N1)pdm09 Influenza in Australia , 2012, The Journal of infectious diseases.

[7]  J. van de Kassteele,et al.  Oseltamivir-Resistant Influenza Virus A (H1N1), Europe, 2007–08 Season , 2009, Emerging infectious diseases.

[8]  A. Moscona.  Neuraminidase inhibitors for influenza. , 2005, The New England journal of medicine.

[9]  A. Kelso,et al.  Community transmission of oseltamivir-resistant A(H1N1)pdm09 influenza. , 2011, The New England journal of medicine.

[10]  R. Pebody,et al.  Continued emergence and changing epidemiology of oseltamivir-resistant influenza A(H1N1)2009 virus, United Kingdom, winter 2010/11. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[11]  J. Oxford,et al.  The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo. , 2002, Antiviral research.

[12]  M. Ison.  Antivirals and resistance: influenza virus. , 2011, Current opinion in virology.

[13]  David Smith,et al.  Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa. , 2009, Antiviral research.

[14]  Gavin J. D. Smith,et al.  Reassortment of Pandemic H1N1/2009 Influenza A Virus in Swine , 2010, Science.